Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Artificial Intelligence in Life Sciences Market Outlook

The global artificial intelligence in life sciences market size attained a value of USD 2,209.90 million in 2023, driven by the rapid technological advancements. The market is expected to grow at a CAGR of 24.7% during the forecast period of 2024-2032 to achieve a value of USD 16,077.94 million by 2032.

Artificial Intelligence in Life Sciences Market Analysis

AI-based programs are capable of scrutinising and cross-referencing through large and complex datasets quickly and accurately, resulting in a more precise list of likely drug options in a shorter duration of time. For example, Buoy Health is an AI-based chatbot that listens to patients’ health issues and related symptoms, and through algorithms, suggests the most appropriate therapy.

artificial intelligence in life sciences market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Enlitic offers deep learning medical tools that assess unstructured records (images, medical history, blood tests, genome reports, EKGs) and helps doctors address patients’ real-time needs.

Drug development is a tedious, time-consuming, and expensive method that entails screening a large number of probable molecules. Further, it takes several years and a significant amount of money to introduce a new drug to the market. AI helps compile the substantial amounts of data obtained from numerous sources (such as research labs and hospitals) in a compatible format, which, in turn, is propelling the artificial intelligence in life sciences market development further.

AI also helps develop better healthcare networks and protocols, expediting their introduction in the market at a reasonable price. In 2021, EY announced the launch of EY Smart Reviewer, a novel technology-driven solution for the life sciences sector. It leveraged AI and natural language processing to help accelerate and improve the process to review materials employed to market pharmaceutical and medical device products. The EY Smart Reviewer solution enabled pharmaceutical and medical technology companies to automate the MLR process and significantly reduce review and approval timelines for modular content, driving faster speed to market for essential medicines.

Artificial Intelligence in Life Sciences Market Segmentations

artificial intelligence in life sciences market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Offering

  • Software
  • Hardware 
  • Services

Market Breakup by Deployment

  • On-Premises
  • Cloud

Market Breakup by Application

  • Research and Development
  • Drug Discovery and Clinical Trials
  • Biotechnology
  • Surgery and Treatment
  • Precision and Personalized Medicine
  • Medical Diagnosis
  • Patient Monitoring
  • Others

Market Breakup by End User

  • Healthcare Providers 
  • Pharmaceutical and Biotechnology Companies 
  • Patients 
  • Payer
  • Others

Market Breakup by Region

  • North America 
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

artificial intelligence in life sciences market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Artificial Intelligence in Life Sciences Market Overview

The application of AI in medicine includes machine learning (ML) (virtual aspect) and deep learning (DL) (physics aspect); in DL, AI is performed by robots. Robotic surgery is a domain that has been gaining significant interest. Today, surgeries may be carried out at sites that were earlier inaccessible with the help of technology like the da Vinci surgical system. Advancements in technology have enabled interaction between humans and robots that enables human surgeons to operate surgical robots through touchless manipulation. Such manipulation is made possible through hand or head movements, voice and speech recognition, or the surgeon's gaze. These developments are expected to contribute to the artificial intelligence in life sciences market growth in the coming years.

Further, artificial intelligence (AI) is set to transform the pharmaceutical cold chain in the next few years. Companies are seeking to develop applications to utilise machine learning to generate predictive data on environmental hazards in the biopharmaceutical cold chain cycle. AI is expected to play a key role in domains including analytical decision-making (by aggregating and analysing data from several sources, AI-based systems could offer complete visibility with predictive data), supply chain management (SCM), inventory management, warehouse automation, and others.

Artificial Intelligence in Life Sciences Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • IBM Corporation
  • NuMedii Inc.
  • Atomwise Inc
  • AiCure LLC
  • Nuance Communications Inc.
  • Databricks
  • IQVIA
  • SAS Institute Inc.
  • Sorcero
  • Indegene

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Offering
  • Deployment
  • Application
  • End User
  • Region
Breakup by Offering
  • Software
  • Hardware 
  • Services
Breakup by Deployment
  • On-Premises
  • Cloud
Breakup by Application
  • Research and Development
  • Drug Discovery and Clinical Trials
  • Biotechnology
  • Surgery and Treatment
  • Precision and Personalized Medicine
  • Medical Diagnosis
  • Patient Monitoring
  • Others
Breakup by End User
  • Healthcare Providers 
  • Pharmaceutical and Biotechnology Companies 
  • Patients 
  • Payer
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • IBM Corporation
  • NuMedii Inc.
  • Atomwise Inc
  • AiCure LLC
  • Nuance Communications Inc.
  • Databricks
  • IQVIA
  • SAS Institute Inc.
  • Sorcero
  • Indegene

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

The market attained a value of USD 2,209.90 million in 2023, driven by the rising technological advancements in the market.

The market is expected to grow at a CAGR of 24.7% to attain a value of USD 16,077.94 million by 2032.

The major drivers of the market include the growing investment in technologies, increasing number of clinical trials, invest in R&D activities, and rising application in initiating drug discovery and development.

The high demand for AI solutions and an increase in the amount of health and “omics-related” data generated and stored are the key trends propelling the market's growth.

The offerings in the market include software, hardware, and services.

The deployment modes in the market can be categorised into on-premises and cloud.

The technology finds wide applications in research and development, drug discovery and clinical trials, biotechnology, surgery and treatment, precision and personalized medicine, medical diagnosis, and patient monitoring, among others.

The end-users can be categorised into healthcare providers, pharmaceutical and biotechnology companies, patients, and payer, among others.

The regional markets can be categorised into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

The key players can be categorised into IBM Corporation, NuMedii Inc., Atomwise Inc, AiCure LLC, Nuance Communications Inc., Databricks, IQVIA, SAS Institute Inc., Sorcero, and Indegene.

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Pricing Plans

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Strategic Solutions for Informed Decision-Making

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124